Literature DB >> 20237418

MicroRNA-210: a unique and pleiotropic hypoxamir.

Stephen Y Chan1, Joseph Loscalzo.   

Abstract

Inadequate oxygen availability or hypoxia induces a complex and still incompletely understood set of adaptations that influence cellular survival and function. Many of these adaptations are directly controlled by a master transcription factor, hypoxia inducible factor-alpha (HIF-α). In response to hypoxia, HIF-α levels increase and directly induce the transcription of > 100 genes, influencing functions ranging from metabolism, survival, proliferation, migration, to angiogenesis, among others. Recently, it has been demonstrated that a specific set of microRNA molecules are upregulated by hypoxia, which we denote here as "hypoxamirs." In particular, the HIF-responsive hypoxamir microRNA-210 (miR-210) is a unique microRNA that is evolutionarily conserved and ubiquitously expressed in hypoxic cell and tissue types. A number of direct targets of miR-210 have been identified by in silico, transcriptional, and biochemical methods, a subset of which have been extensively validated. As a result, miR-210 has been mechanistically linked to the control of a wide range of cellular responses known to influence normal developmental physiology as well as a number of hypoxia-dependent disease states, including tissue ischemia, inflammation, and tumorigenesis. Thus, reflecting the pleiotropic actions of HIF-α, miR-210 appears to function as a "master microRNA" relevant for the control of diverse functions in the hypoxic state.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20237418      PMCID: PMC2912143          DOI: 10.4161/cc.9.6.11006

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  99 in total

Review 1.  Regulation of angiogenesis by Eph-ephrin interactions.

Authors:  Sanne Kuijper; Christopher J Turner; Ralf H Adams
Journal:  Trends Cardiovasc Med       Date:  2007-07       Impact factor: 6.677

Review 2.  New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites.

Authors:  Isidore Rigoutsos
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

3.  New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites.

Authors:  Inhan Lee; Subramanian S Ajay; Jong In Yook; Hyun Sil Kim; Su Hyung Hong; Nam Hee Kim; Saravana M Dhanasekaran; Arul M Chinnaiyan; Brian D Athey
Journal:  Genome Res       Date:  2009-03-31       Impact factor: 9.043

4.  Identification of a new fibroblast growth factor receptor, FGFR5.

Authors:  M Sleeman; J Fraser; M McDonald; S Yuan; D White; P Grandison; K Kumble; J D Watson; J G Murison
Journal:  Gene       Date:  2001-06-27       Impact factor: 3.688

5.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

6.  The expression of Argonaute2 and related microRNA biogenesis proteins in normal and hypoxic trophoblasts.

Authors:  Rogier B Donker; Jean-François Mouillet; D Michael Nelson; Yoel Sadovsky
Journal:  Mol Hum Reprod       Date:  2007-02-27       Impact factor: 4.025

7.  Human HIF-3alpha4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma.

Authors:  Mindy A Maynard; Andrew J Evans; Tomoko Hosomi; Shuntaro Hara; Michael A S Jewett; Michael Ohh
Journal:  FASEB J       Date:  2005-09       Impact factor: 5.191

8.  Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies.

Authors:  Xiao-ming Zhu; Tao Han; Ian L Sargent; Guo-wu Yin; Yuan-qing Yao
Journal:  Am J Obstet Gynecol       Date:  2009-03-14       Impact factor: 8.661

Review 9.  microRNA: emerging therapeutic targets in acute ischemic diseases.

Authors:  Pasquale Fasanaro; Simona Greco; Mircea Ivan; Maurizio C Capogrossi; Fabio Martelli
Journal:  Pharmacol Ther       Date:  2009-11-06       Impact factor: 12.310

10.  The stability and robustness of metabolic states: identifying stabilizing sites in metabolic networks.

Authors:  Sergio Grimbs; Joachim Selbig; Sascha Bulik; Hermann-Georg Holzhütter; Ralf Steuer
Journal:  Mol Syst Biol       Date:  2007-11-13       Impact factor: 11.429

View more
  166 in total

1.  Synthesis and Evaluation of Chloroquine-Containing DMAEMA Copolymers as Efficient Anti-miRNA Delivery Vectors with Improved Endosomal Escape and Antimigratory Activity in Cancer Cells.

Authors:  Ying Xie; Fei Yu; Weimin Tang; Bolutito Oluwole Alade; Zheng-Hong Peng; Yazhe Wang; Jing Li; David Oupický
Journal:  Macromol Biosci       Date:  2017-08-04       Impact factor: 4.979

Review 2.  MicroRNAs in skin and wound healing.

Authors:  Jaideep Banerjee; Yuk Cheung Chan; Chandan K Sen
Journal:  Physiol Genomics       Date:  2010-10-19       Impact factor: 3.107

3.  Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function.

Authors:  Ha Won Kim; Shujia Jiang; Muhammad Ashraf; Khawaja Husnain Haider
Journal:  J Mol Med (Berl)       Date:  2012-05-31       Impact factor: 4.599

4.  Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis.

Authors:  Goutam Ghosh; Indira V Subramanian; Neeta Adhikari; Xiaoxiao Zhang; Hemant P Joshi; David Basi; Y S Chandrashekhar; Jennifer L Hall; Sabita Roy; Yan Zeng; Sundaram Ramakrishnan
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

5.  The cellular response to hypoxia: tuning the system with microRNAs.

Authors:  Joseph Loscalzo
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

6.  Changes in microglial inflammation-related and brain-enriched MicroRNAs expressions in response to in vitro oxygen-glucose deprivation.

Authors:  Huimin Kong; Ahmed Omran; Muhammad Usman Ashhab; Na Gan; Jing Peng; Fang He; Liwen Wu; Xiaolu Deng; Fei Yin
Journal:  Neurochem Res       Date:  2013-12-12       Impact factor: 3.996

7.  MicroRNAs in Cerebral Ischemia.

Authors:  Kai-Ying Lim; Jia-Hui Chua; Jun-Rong Tan; Priyadharshni Swaminathan; Sugunavathi Sepramaniam; Arunmozhiarasi Armugam; Peter Tsun-Hon Wong; Kandiah Jeyaseelan
Journal:  Transl Stroke Res       Date:  2010-12       Impact factor: 6.829

Review 8.  Neural stem cell therapies and hypoxic-ischemic brain injury.

Authors:  Lei Huang; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2018-05-21       Impact factor: 11.685

Review 9.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

10.  MiR-210 expression reverses radioresistance of stem-like cells of oesophageal squamous cell carcinoma.

Authors:  Xin Chen; Jia Guo; Ru-Xing Xi; Yu-Wei Chang; Fei-Yang Pan; Xiao-Zhi Zhang
Journal:  World J Clin Oncol       Date:  2014-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.